Medpace Holdings ($MEDP (+3,24%) ) reports Q1 2025 earnings:
Q1 2025:
Sales: 558.6M vs. 527M expected (+6%) 🟢
EBITDA: 118.6M vs. 118M expected (+0.5%) 🟡
EBIT: 113.5M vs. 109M expected (+4.1%) 🟢
Net Income: 114.6M vs. 96M expected (+19.3%) 🚀
Outlook for FY2025:
Sales: 2190M vs. 2149M expected (+1.9%) 🟡
EBITDA: 477M vs. 477M expected (+0%) 🟡
Net Income: 390.0M vs. 387M expected (+0.7%) 🟡
eine Milliarde Aktienrückkaufprogramm angekündigt. Book-to-Bill fällt allerdings weiter auf 0.9 (von 0.99)